Abstract
Clinical OMICsVol. 6, No. 6 Liquid BiopsyLiquid Biopsy: A Year in Review Evolving from analytical validation to clinical utilityLuca Quagliata, Ph.D.Luca Quagliata, Ph.D.Luca Quagliata, PhD, is the global head of medical affairs for clinical NGS and oncology at Thermo Fisher Scientific. He is a faculty member for the Certificate of Advanced Study (CAS) in Personalized Molecular Oncology at the University of Basel and was previously the lab director at the Institute of Medical Genetics and Pathology at the University Hospital Basel, Switzerland.Search for more papers by this authorPublished Online:5 Nov 2019https://doi.org/10.1089/clinomi.06.06.14AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 6Issue 6Nov 2019 InformationCopyright © GEN PublishingTo cite this article:Luca Quagliata, Ph.D..Liquid Biopsy: A Year in Review Evolving from analytical validation to clinical utility.Clinical OMICs.Nov 2019.24-26.http://doi.org/10.1089/clinomi.06.06.14Published in Volume: 6 Issue 6: November 5, 2019PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
